Analysis on characteristics of microbiome structure in non-small cell lung cancer patients
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [28]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    [Objective] To describe and compare the structure of intestinal microbiota between patients with non-small cell lung cancer and benign lung disease and explore the influence of specific microbial flora in the lung cancer.[Methods] We collected 63 cases of fecal samples which including 39 non-small cell lung cancer patients and 24 benign lung disease patients and use high-throughput second-generation sequencing technology platform to analyze the V3-V4 region of 16S rDNA gene in fecal samples of bacteria to explore the overall structural characteristic of intestinal microbiota.[Results] Lachnospira, Ruminococcus, Faecalibacterium, Roseburia, Fusicatenibacter are significantly enriched in lung adenocarcinoma patients. But in lung squamous cell carcinoma and benign lesions there is no obvious difference. And Haemophilus, Prevotella, Streptococcus, Citrobacter are significantly enriched in the intestines of patients with benign diseases.[Conclusions] Non-small cell lung cancer and benign diseases have different gut microbiome.

    Reference
    [1] Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou XN, Chen R, Gu XY, Wei WQ, He J. Report of cancer epidemiology in China, 2015. Chinese Journal of Oncology, 2019, 41(1):19-28. (in Chinese) 郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小农, 陈茹, 顾秀瑛, 魏文强, 赫捷. 2015年中国恶性肿瘤流行情况分析. 中华肿瘤杂志, 41(1):19-28.
    [2] Mao Y, Yang D, He J, Krasna M J. Epidemiology of lung cancer. Surgical Oncology Clinics of North America, 2016, 25(3):439-445.
    [3] Chen WQ, Zheng RS, Zeng HM, Zhang SW. Epidemiology of lung cancer in China. Thoracic Cancer, 2015, 6(2):209-215.
    [4] de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiologic Clinics of North America, 2012, 50(5):863-876.
    [5] Lee JT, Kim CM, Ramakrishnan V. Microbiome and disease in the upper airway. Current Opinion in Allergy and Clinical Iimmunology, 2019, 19(1):1-6.
    [6] Lynch SV. The lung microbiome and airway disease. Annals of the American Thoracic Society, 2016, 13 Suppl 2(Suppl 5):S462-5.
    [7] Budden KF, Gellatly SL, Wood DLA, Cooper MA, Morrison M, Hugenholtz P, Hansbro PM. Emerging pathogenic links between microbiota and the gut-lung axis. Nature Reviews Microbiology, 2017, 15(1):55-63.
    [8] Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, Delhaes L. The gut-lung axis in health and respiratory diseases:a place for inter-organ and inter-kingdom crosstalks. Frontiers in Cellular and Infection Microbiology, 2020, 10:9.
    [9] He Y, Wen Q, Yao FF, Xu D, Huang YC, Wang JS. Gut-lung axis:the microbial contributions and clinical implications. Critical Reviews in Microbiology, 2017, 43(1):81-95.
    [10] Dumas A, Bernard L, Poquet Y, Lugo-Villarino G, Neyrolles O. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cellular Microbiology, 2018, 20(12):e12966.
    [11] Zhuang H, Cheng L, Wang Y, Zhang YK, Zhao MF, Liang GD, Zhang MC, Li YG, Zhao JB, Gao YN, Zhou YJ, Liu SL. Dysbiosis of the gut microbiome in lung cancer. Frontiers in Cellular and Infection Microbiology, 2019, 9:112.
    [12] Zheng YJ, Fang ZY, Xue Y, Zhang J, Zhu JJ, Gao RY, Yao S, Ye Y, Wang SH, Lin CD, Chen SY, Huang H, Hu L, Jiang GN, Qin HL, Zhang P, Chen JF, Ji HB. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes, 2020, 11(4):1030-1042.
    [13] Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. Journal of Clinical Oncology, 2015, 33(17):1889-1894.
    [14] Hansen JJ. Immune responses to intestinal microbes in inflammatory bowel diseases. Current Allergy and Asthma Reports, 2015, 15(10):1-8.
    [15] Jin YP, Dong H, Xia LL, Yang Y, Zhu YQ, Shen Y, Zheng HJ, Yao CC, Wang Y, Lu S. The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC. Journal of Thoracic Oncology, 2019, 14(8):1378-1389.
    [16] Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Letters, 2016, 382(2):240-244.
    [17] Tyl M, Domagała-Kulawik J. Lung cancer and copd-growing clinical problem.Polski Merkuriusz Lekarski:Organ Polskiego Towarzystwa Lekarskiego, 2017, 43(253):5-9.
    [18] Houghton AM. Mechanistic links between COPD and lung cancer. Nature Reviews Cancer, 2013, 13(4):233-245.
    [19] Pang T, Leach ST, Katz T, Day AS, Ooi CY. Fecal biomarkers of intestinal health and disease in children. Frontiers in Pediatrics, 2014, 2:6.
    [20] Rangan KJ, Hang HC. Biochemical mechanisms of pathogen restriction by intestinal bacteria. Trends in Biochemical Sciences, 2017, 42(11):887-898.
    [21] Zhou YJ, Zhao DD, Liu HD, Chen HT, Li JJ, Mu XQ, Liu Z, Li X, Tang L, Zhao ZY, Wu JH, Cai YX, Huang YZ, Wang PG, Jia YY, Liang PQ, Peng X, Chen SY, Yue ZL, Yuan XY, Lu T, Yao BQ, Li YG, Liu GR, Liu SL. Cancer killers in the human gut microbiota:diverse phylogeny and broad spectra. Oncotarget, 2017, 8(30):49574-49591.
    [22] Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G. The microbiota of breast tissue and its association with breast cancer. Applied and Environmental Microbiology, 2016, 82(16):5039-5048.
    [23] Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, Song Y. Chlamydia pneumoniae infection and lung cancer risk:a meta-analysis. European Journal of Cancer:Oxford, England, 2011, 47(5):742-747.
    [24] Zhai K, Ding J, Shi HZ. HPV and lung cancer risk:a meta-analysis. Journal of Clinical Virology:the Official Publication of the Pan American Society for Clinical Virology, 2015(63):84-89
    [25] Khan S, Imran A, Khan AA, Abul Kalam M, Alshamsan A. Systems biology approaches for the prediction of possible role of chlamydia pneumoniae proteins in the etiology of lung cancer. PLoS ONE, 2016, 11(2):e0148530.
    [26] Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology, 2017, 151(4):363-374.
    [27] Daniel S G, Ball C L, Besselsen D G, Doetschman T, Hurwitz B L. Functional changes in the gut microbiome contribute to transforming growth factor β-deficient colon cancer. mSystems, 2017, 2(5):e00065-17
    [28] Vivarelli S, Salemi R, Candido S, Falz楯癮楥猠?愬甠浓污?歴歡?偡???桍椬琠湓楴獥?呡??搠敓??慔杯敲物?偯???儠畂楡湮瑮慡渠慇??????敮物扮敩爠??????牲祡????均敵楴渠敭物??????汴瑡攠牡慮瑤椠潣湡獮?潥晲?瑦桲敯?栠異浡慴湨?杧略瑮?浳楩捳爠潴扯椠潴浨敥?楡湰?洮甠氼瑩椾灃污敮?獥捲汳攼爯潩猾椬猠?‰?椹?丠愱琱用爱攩??漸洮洼畢湲椾捛愲琹楝漠湂獩??楩???㈠ぎ???????水?????扥牬?嬠??崠??潴獡瑮椠捒???????栠界測????剩漠扅攬爠瑎獩潫湫…????氻楬捡欠浊愬渠???乴???愬氠汓楡湴楯???????椠捆桲慡畮摣?????氠慃測挠祂?呩?????桐甬渠杄???????漮挠桔桨敲慯摵?偨???潥汩摮???????汢?佹浯慮牤???????牣敲湯湢敩牯?????畤挠桩獮???卭???敯祲敹爠獳潴湡?????慮爠牳敥瑮瑩?坲?匠???甠獣潥扮慴捥瑮敡牲楩畡浮?渮甠挼汩放慐瑌畯浓?灏潎瑅攼港瑩椾愬琠攲猰?椰測琠攵猨琵椩渺慥氱‰琶甶洷漮爼楢杲放湛攳猰楝猠?慩湮摧?浬潡搠畒氬愠瑆敩獬?瑩桲敥?瑍甬洠潒牡?楯浳浥當湩散?浒楯换物潮攠湎瘬椠牂潥湹洠敍測琠???楴??敮氠汊??漬猠瑂??慮浡灬???椭捄牯潮扡敤??楬???水???????????水????????戠牅?嬠??嵳??汥慤渠摴敵牲???????漿渠杇浵慴渭?創?卧???汩楳攬瘠??????却潹測渠敡湮扤攠牬杵???????牥瑲椮猠????副敵杲畮污慬琠楯潦渠?潮晣?楬湯晧汹愼洯浩愾琬椠漲渰?户礬?洲椰挱爷漨戵椰漳琵愳?椱温琮攼牢慲挾瑛椳漱湝猠?睵楥瑲桶?琠桁攬?桓潡獬瑡???椠?丬愠瑒畵牡敳??浡浤畩湥潤汯漠材礬??極????の????????????????ぬ??戠牓?嬠??嵢?婲椠瑦癲潯杭攠污?????祬祡潲甠扤????剩潳甠瑤祩?????特漠敡浳敳牯?????楤挠牷潩扴楨漠浦敥?慡湬搠?慨湯瑲楴挭慣湨捡敩牮?楦浡浴畴湹漠獡畣物癤攠楣汯汮慣湥据整???楩??敳氠汩??楴????ぬ????????????????????扒牥?孥?ひ嵣??漨灎慥汷愠歙牯楲獫栬渠慎湙?嘼??匾瀬攠渲挰攱爳??丳??丱攰稩椺????券攱甶戮攼湢???″?湝搠牁整睡獲??????愬爠灔楡湮敯瑵獥?呔嘬??偳牨楩敭瑡漠?倬???噤楡挠敗測琠敎?????漠晙昬洠慎湩????坡敷楡?午????潫杵摤楡氠汓??偓??婴桯愠潔?????畵摳杨敩湭獡??圬???畳瑥挠桋椬渠獋潩湭??匬???慩湴空漠?呖??偗敩瑬慭捥捳椠慐?搠敕??慡挠敓搬漠?????潳瑨敩捭桡椠湋椬?呏???甠浈愬爠?呬???桂攬渠?坡卫??創散摨摩礠?匬???卮穩捧穵散灨慩渠楔愬欠?卯汲潩慴湡攠?刬???慴汴汯潲睩愠祍?倠效湯慮?????椠慔湲来?????桵散湴?偯???卹栠灡愠汲污?????剬敬穹瘠慳湥楬?????氠潭畩獸楴??????栠攼浩愾汃祬?剳???卤桩敡氼戯畩爾渠敳?卲??噮敳渠捦敲?????佥欠桨畵祭獡敮渠?偩????敩湯獴敡渮?嘼???卡睴敵湲湥攼猯????′?挱?氬氠椵猰琰攨爷?????愲爳挲攭氲漳?刮椼煢畲放汛洳攳?匠慄湡捶桩敤稠????婍桡慵湲杩?奥???攬??桡慲瑭敯汤楹攠牒????婯楯瑴癥潮杢敥汲????倬漠湂獵?乴???畊獅琬椠湗??牦敥渠敂浅愬渠??????慖礬搠畄??????畁牓琬漠湖??????愬爠摆湩敳牣?????匠楍牁洬愠湂獩?????略?????愠穄慵牴?????告猬甠橔極歲慮睢慡?呧???楊愮戠????吠慲睡扰楩?????汮楤琠穲慥??????睩畢?坹???側慥瑲敳氠?卨健??坵潭潡摮洠慧湵?匠????浯慢物楯慭?刮丠???慎癡楴敵獲???? ̄?攠爲猰栱攴測眠愵氰搵??????眺电‵倹?‵?攳攮?????娳栴慝渠杌?????潺甠獂獅攮渠獃??????潥漠灰敡牴?婥????畩瑮爠数慡汴?健????慷湩楴敨氠??剮???樺慡洠楳?乳???偡整瑩牣漠獲楥湶潩?????呩放瑔穨汥愠晌晡??呥??协桮慣牯浬慯?偹???氾氬椠猲漰渱″?倠???收温焺′刱券?′圲愸爮朼潢????‵?甠瑎?浳楨捩牤潡戠楁漬洠敉?浯潵摥甠汒愬琠敉獮?牴敯獭灩漠湏猬攠?瑡潭?慡渠瑓椬?偎????椠浙洬甠湁潮瑤桯敨爠慁瀮礠?極湴?浭敩汣慲湯潢浩慯?灡愠瑩楮攠湴瑨獥???楴?卯捧楥敮湥捳敩??楯????て??????????????????び???扥爮?嬼??嵃??潮湩杣?????桵敲桮牡慬稠楯?删慇晡晳汴敲????健汲慯捬敯湧捹椼漯??椬挠欲漰欱?嘬???用愱温?????攮渼摢楲显慛爳????卡慮汧杩椠慓?删??呮桤敨?朠畒琬?浃楯捸爠潌才椬漠浌敩?慎測搠?牯敮猠灇潬湥獨敮?瑆漬?楙浡浮甠湒攬?捐桡整捥歬瀠潂椬渠瑍?楺湺桯楬扡椠瑍潁爬猠?灩牵攠捓汒椬渠楇捬慡汮?愠湂摌?挠汃楯湯楫挠慓氬?獔瑡牮慫瑯敵朠楓攬猠???楡??氠楆測椠捍慥汬?愠湋搬?呎牥慪湡獤氠慐琬椠潓湭慩汴??敋搬椠捔楯湰攦??楥???学ふ???????????den J, K
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Wenjie Yuan, Yaqiong Guo, Yi Han, Baoli Zhu. Analysis on characteristics of microbiome structure in non-small cell lung cancer patients. [J]. Acta Microbiologica Sinica, 2021, 61(9): 2776-2790

Copy
Share
Article Metrics
  • Abstract:374
  • PDF: 1047
  • HTML: 1350
  • Cited by: 0
History
  • Received:November 06,2020
  • Revised:January 23,2021
  • Online: September 04,2021
Article QR Code